Also listed on Biocept, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Mar 24, 2030 · High confidence
20-year base term ends Mar 24, 2030
Held by Plus Therapeutics, Inc.
Filed Mar 24, 2014 as application 14/223,980 · Granted Jun 6, 2017
Base term, 20 years from filing
Today
2010
2030
Clock starts
Mar 24, 2010
Mar 24, 2010
Term ends
Mar 24, 2030
Mar 24, 2030
Granted
Jun 6, 2017
Jun 6, 2017
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,128,082, to Mar 24, 2030. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 24, 2010, when application 12/730,738, the earliest non-provisional in its chain, was filed (this one was filed Mar 24, 2014) | Mar 24, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,128,082) | resolves to Mar 24, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 24, 2030 | High confidence |
This family
| US 9,128,082 | In force Oct 2031 | Oct 2031 |
| Application 13/269,532 | Abandoned not computed | not computed |
| US 9,671,407 | this patent Mar 2030 | Mar 2030 |
| US 10,527,611 | In force Jan 2031 | Jan 2031 |
| US 11,719,692 | In force Oct 2031 | Oct 2031 |
| Application 18/334,185 | Abandoned not computed | not computed |
| Application 19/546,605 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 9, 2016 Reel 40958, frame 222 | Mikolajczyk, Stephen D.; Pircher, Tony; Bischoff, Farideh Z.; Tsinberg, Pavel | Biocept, Inc. | Assignment of Assignor's Interest |
| Jan 9, 2017 Reel 40903, frame 895 | Mikolajczyk, Stephen D.; Pircher, Tony; Bischoff, Farideh Z.; Tsinberg, Pavel | Biocept, Inc. | Assignment of Assignor's Interest |
| Aug 30, 2026 Reel 76288, frame 260 | Plus Therapeutics, Inc. | Cerenome, Inc. | Change of Name |
| Sep 16, 2026 Reel 76505, frame 1 | Cerenome, Inc.; Cnside Diagnostics, LLC | 3I, LP | Security Interest |
| Nov 10, 2026 Reel 76705, frame 66 | Biocept, Inc. | Plus Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Mar 2030
Term ends Mar 24, 2030. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,128,082, ends no earlier than this term, so it caps nothing.
Citations
10
later US patents cite this one
That is above the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.